Barrios-Garay K, Agudelo-Sánchez LF, Aguirre-Urizar JM, Gay-Escoda C. Analyses of odontogenic tumours: the most recent classification proposed by the World Health Organization (2017). Med Oral Patol Oral Cir Bucal. 2020 Nov 1;25 (6):e732-8.
doi:10.4317/medoral.23751
https://dx.doi.org/doi:10.4317/medoral.23751
1. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg P, eds. WHO classification of head and neck tumours. 4th ed. Lyon: IARC Press; 2017. |
2. Pindborg JJ, Kramer IRH, Torloni H. WHO histological typing of odontogenic tumours, jaw cysts, and allied lesions. Geneva: World Health Organization; 1971. |
3. Kramer IRH, Pindborg JJ, Shear M. WHO histological typing of odontogenic tumors. 2nd ed. Berlin: Springer-Verlag; 1992. |
4. Barnes L, Eveson J, Reichart P, Sidransky D, eds. World Health Organization classification. Pathology and genetics of head and neck tumors. 3rd ed. Lyon: IARC Press; 2005. |
5. Wright JM, Odell E, Speight PM, Takata T. Odontogenic tumors, WHO 2005: Where do we go from here?. Head Neck Pathol. 2014;8:373-82. |
PMid:25409849 PMCid:PMC4245407 |
6. Wright JM, Vered M. Update from the 4th Edition of the World Health Organization classification of head and neck tumours: Odontogenic and maxillofacial bone tumors. Head Neck Pathol. 2017;11:68-77. |
PMid:28247226 PMCid:PMC5340735 |
7. Kennedy RA. WHO is in and WHO is out of the mouth, salivary glands, and jaws section of the 4th edition of the WHO classification of head and neck tumours. Br J Oral Maxillofac Surg. 2018;56:90-5. |
PMid:29352614 |
8. Ebell MH, Siwek J, Weiss BD, Woolf SH, Susman J, Ewingman B, et al. Strength of recommendation taxonomy (SORT): A patient centered approach to grading evidence in the medical literature. J Am Board Fam Pract. 2004;17:59-67. |
PMid:15014055 |
9. Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoSMed. 2009;6:e1000097. |
PMid:19621072 PMCid:PMC2707599 |
10. Koutlas IG, Allen CM, Warnock GR, Manivel JC. Sclerosing odontogenic carcinoma: A previously unreported variant of a locally aggressive odontogenic neoplasm without apparent metastatic potential. Am J Surg Pathol. 2008;39:1613-19. |
PMid:18753945 |
11. Ide F, Kikuchi K, Kusama K. Sclerosing odontogenic carcinoma. Pathol Int. 2011;61:259-61. |
PMid:21418400 |
12. Hussain O, Rendon AT, Orr RL, Speight PM. Sclerosing odontogenic carcinoma in the maxilla: A rare primary intraosseous carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116:e283-e6. |
PMid:23567261 |
13. Mosqueda-Taylor A, Pires FR, Aguirre-Urízar JM, Carlos-Bregni R, de la Piedra-Garza JM, Martínez-Conde R, et al. Primordial odontogenic tumour: Clinicopathological analysis of six cases of a previously undescribed entity. Histopathology. 2014;65:606-12. |
PMid:24807692 |
14. Lei Y, Jaradat JM, Owosho A, Adebiyi KE, Lybrand KS, Neville BW, et al. Evaluation of SOX2 as a potential marker for ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117:608-16. |
PMid:24603057 |
15. Richardson MS, Muller S. Malignant odontogenic tumors: An update on selected tumors. Head Neck Pathol. 2014;8:411-20. |
PMid:25409848 PMCid:PMC4245406 |
16. Gong Y, Wang L, Wang H, Li T, Chen X. The expression of NF-κβ, Ki-67 and MMP-9 in CCOT, DGCT and GCOC. Oral Oncol. 2009;45:515-20. |
PMid:18723387 |
17.Yancoskie AE, Sreekantaiah C, Jacob J, Rosenberg A, Edelman M, Antonescu CR, et al. EWSR1 and ATF1 rearrangements in clear cell odontogenic carcinoma: Presentation of a case. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:e115-e8. |
PMid:24721473 |
18. Mosqueda-Taylor A, Neville BW, Tatemoto Y, Ogawa I, Takata T. Odontogenic carcinoma with dentinoid: A new odontogenic carcinoma. Head Neck Pathol. 2014;8:421-31. |
PMid:25409850 PMCid:PMC4245409 |
19. Chikosi R, Segall N, Augusto P, Freedman P. Odontogenic carcinosarcoma: Case, report and literature review. J Oral Maxillofac Surg. 2011;69:1501-7. |
PMid:21195529 |
20. Sweeney RT, McClary AC, Myers BR, Biscocho J, Neahring L, Kwei KA, et al. Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nat Genet. 2014;46:722-5. |
PMid:24859340 PMCid:PMC4418232 |
21. Kurppa KF, Caton J, Morgan PR, Ristimaki A, Ruhin B, Kellokoski J, et al. High frequency of BRAF V600E mutations in ameloblastoma. J Pathol. 2014;232:492-8. |
PMid:24374844 PMCid:PMC4255689 |
22. Diniz MG, Gomes CC, Guimarães BV, Castro WH, Lacerda JC, Cardoso SV, et al. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours. Tumour Biol. 2015;36:5649-53. |
PMid:25854168 |
23. Pereira NB, Pereira KM, Coura BP, Diniz MG, de Castro WH, Gomes CC, et al. BRAFV600E mutation in the diagnosis of unicystic ameloblastoma. J Oral Pathol Med. 2016;45:780-5. |
PMid:27084044 |
24. Dissanayake RK, Jayasooriya PR, Siriwardena DJ, Tilakaratne WM. Review of metastasizing (malignant) ameloblastoma (METAM): Pattern of metastasis and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111:734-41. |
PMid:21459020 |
25. Kaye FJ, Ivey AM, Drane WE, Mendehall WM, Allam RW. Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma. J Natl Cancer Inst. 2015;107:dju378. |
PMid:25475564 |
26. Broudic M, Blay JY, Vazquez L, Evrard A, Karanian M, Taïeb S, et al. Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: A case report. J Med Case Rep. 2019;13:245-63. |
PMid:31340860 PMCid:PMC6657072 |
27. Buchner A, Vered M. Ameloblastic fibroma: A stage in the development of a hamartomatous odontoma or a true neoplasm? Critical analysis of 162 previously reported cases plus 10 new cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116:598-606. |
PMid:24055148 |